Neurology Central

World’s first iPS trial approved in Japan for spinal cord injuries

0
Earlier this week, Japan’s health ministry approved the world’s first clinical trial for the treatment of spinal cord injuries using induced pluripotent stem cells (iPS), according to a report from The Japan Times.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.

Share: